Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy

... which has previously achieved successful phase II results in patients with cat allergies. Ragweed is one of the leading causes of allergic reactions in No...h technology. We have already achieved encouraging results in patients with cat allergies, and are excited to be extending our portfolio of therapies to en...

One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials

...- in the United States, Canada, and abroad -- have had an impact on everything from health care (the pacemaker from the University of Minnesota , the cat scan from Georgetown, laser cataract surgery from the University of California-Los Angeles ) to better living at home (plexiglass from McGill Univer...

Circassia's Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients

...t study, which is underway in Canada, will enrol 48 patients with confirmed cat allergies and cat-allergen induced asthma. The randomised, double-blind, pl...current treatments is approximately $12 billion per year. The prevalence of cat allergies is also high, with 1-in-6 Americans and nearly 10% of Europeans s...

Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment

...cruitment for a further phase II clinical trial in cat allergy. The study, which is underway in Canada, h...t of the ongoing study, each patient is exposed to cat allergens in a controlled environmental exposure c...roximately $12 billion per year. The prevalence of cat allergies is high, with 1-in-6 Americans and nearl...

Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology

...dy of its ToleroMune(R) technology in the field of cat allergy. The trial builds on positive results achi...nts experienced substantially reduced reactions to cat allergens after a single administration of ToleroM... study, patients will receive a controlled dose of cat allergen in an environmental exposure chamber both...

Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology

...allergy technology, ToleroMune(R), in the field of cat allergy. The trial showed that ToleroMune treatmen...llergic reactions to the allergen that causes most cat allergies, and importantly was well tolerated by a...ermany, where patients with a confirmed history of cat allergies received a single dose of ToleroMune the...

Diagnostic Center for Disease: Prostate Biopsy Spreads Prostate Cancer Cells

...the most sensitive and specific diagnostic modality for the prostate evaluation in the world, replacing substandard scanning procedures like PET scan, cat scan and Prostascint scans. The MRI -S at 3.0 Tesla allows imaging of the entire prostate, thereby, creating a roadmap; thereby, allowing selective ta...

Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study

...million in loan-based project financing to accelerate the development of Dynavax's allergy franchise, including TOLAMBA and the preclinical peanut and cat allergy programs. Repayment of a portion of the loans for TOLAMBA is contingent upon the positive outcome of the chamber study. If the TOLAMBA program...

One Shot of Gene Therapy Spreads Through Brain in Animal Study

...rage disease, called alpha- mannosidosis, in cats. In that study, a treated cat showed dramatic improvement in walking, compared to an untreated cat with the disease. If the animal results can be successfully extrapolated t...